Debiao Li, Ph.D.
Biomedical Research Institute, Cedars-Sinai Medical Center, Los Angeles, California
Graham Lidgard, Ph.D.
Exact Sciences, Madison, Wisconsin
Anirban Maitra, M.B.B.S.
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Lynn M. Matrisian, Ph.D., M.B.A.
Pancreatic Cancer Action Network, Manhattan Beach, California
Stephen Pandol, M.D.‡
Director of the Basic and Translational Pancreas Research Program, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California
Sung Poblete, R.N., Ph.D.
Stand Up To Cancer, Los Angeles, California
Michael Rosenthal, M.D., Ph.D.§
Department of Radiology, Dana-Farber Cancer Institute, Boston, Massachusetts
Anil K. Rustgi, M.D.‡
Department of Medicine, Division of Digestive & Liver Diseases, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York
Chris Sander, Ph.D.
Sander Lab, Dana-Farber Cancer Institute, Boston, Massachusetts
Lawrence H. Schwartz, M.D.
Department of Radiology, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York
Uri Shalit, Ph.D.
Faculty of Industrial Engineering and Management, Technion – Israel Institute of Technology, Haifa, Israel
Sudhir Srivastava, Ph.D., M.P.H., M.S.
Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland
James A. Taylor, M.D.+
Google Health, Seattle, Washington
Brian Wolpin, M.D., M.P.H.
Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts
Adam Yala, Ph.D. candidate+
MIT CSAIL, Cambridge, Massachusetts
*Co-leaders, Progress, Problems, and Prospects of Early Detection
+Co-leaders, AI and Machine Learning
§ Co-leaders, AI and Early Detection of Pancreatic Cancer – Current Efforts
‡ Co-leaders, Collaborative Opportunities